Jordan: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Jordan

The Jordanian prophylactic medicaments containing insulin market rose slightly to $X in 2022, picking up by 2.5% against the previous year. Over the period under review, the total consumption indicated a prominent increase from 2012 to 2022: its value increased at an average annual rate of +6.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -2.3% against 2020 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; afterwards, it flattened through to 2022.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Jordan

In value terms, prophylactic medicaments containing insulin production reached $X in 2022 estimated in export price. Overall, the total production indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of +6.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -2.4% against 2020 indices. The pace of growth was the most pronounced in 2016 when the production volume increased by 43%. Prophylactic medicaments containing insulin production peaked at $X in 2020; afterwards, it flattened through to 2022.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Jordan

Prophylactic medicaments containing insulin exports from Jordan surged to X tons in 2022, jumping by 98% against 2021 figures. Overall, exports enjoyed buoyant growth. The most prominent rate of growth was recorded in 2016 with an increase of 391% against the previous year. As a result, the exports attained the peak of X tons. From 2017 to 2022, the growth of the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. Over the period under review, exports posted resilient growth. The growth pace was the most rapid in 2016 with an increase of 749% against the previous year. As a result, the exports reached the peak of $X. From 2017 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

Free Zones (X tons) was the main destination for prophylactic medicaments containing insulin exports from Jordan, accounting for a 59% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Free Zones exceeded the volume sent to the second major destination, Libya (X kg), threefold. The third position in this ranking was taken by Iraq (X kg), with an 8% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Free Zones totaled +18.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: Libya (+54.0% per year) and Iraq (+58.4% per year).

In value terms, Free Zones ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Jordan, comprising 82% of total exports. The second position in the ranking was held by Iraq ($X), with an 11% share of total exports. It was followed by Libya, with a 4% share.

From 2012 to 2022, the average annual rate of growth in terms of value to Free Zones totaled +20.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: Iraq (+35.3% per year) and Libya (+15.1% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, remaining constant against the previous year. Over the period under review, the export price, however, enjoyed a modest expansion. The most prominent rate of growth was recorded in 2016 when the average export price increased by 73% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2020; however, from 2021 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Free Zones ($X per ton), while the average price for exports to Qatar ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Somalia (+2.9%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Jordan

In 2022, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses increased by 41% to X tons for the first time since 2018, thus ending a three-year declining trend. In general, imports continue to indicate a prominent expansion. The pace of growth appeared the most rapid in 2016 with an increase of 152% against the previous year. Over the period under review, imports attained the peak figure at X tons in 2018; however, from 2019 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports surged to $X in 2022. Over the period under review, imports saw a resilient increase. The most prominent rate of growth was recorded in 2016 with an increase of 91%. Over the period under review, imports reached the peak figure at $X in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

Imports by Country

Germany (X tons), France (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Jordan, with a combined 87% share of total imports.

From 2012 to 2022, the biggest increases were recorded for France (with a CAGR of +48.9%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), France ($X) and Denmark ($X) appeared to be the largest prophylactic medicaments containing insulin suppliers to Jordan, together comprising 87% of total imports.

France, with a CAGR of +57.9%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, falling by -1.5% against the previous year. Over the period under review, import price indicated a strong increase from 2012 to 2022: its price increased at an average annual rate of +6.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price decreased by -7.6% against 2020 indices. The pace of growth was the most pronounced in 2020 when the average import price increased by 51%. As a result, import price attained the peak level of $X per ton. From 2021 to 2022, the average import prices remained at a somewhat lower figure.

Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from France ($X per ton) and Denmark ($X per ton), while the price for Brazil ($X per ton) and Germany ($X per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (+16.7%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform